āagmanLoginNot investment advice. Data and computed figures, for information only.
OneSource Specialty Pharma Ltd
₹1,433.20
−₹9.20 (−0.64%)
NSE · 15 Oct 2026, close
Market Cap
₹16,757 Cr
CMP
₹1,433.20
52-wk High / Low
₹1,925 / 1,057
P/B
2.9
Book Value
₹509.0
Div Yield
0.00%
ROCE
1.0%
ROE
−1.1%
Face Value
₹1
D/E
0.22
Price−23.4% over 1Y
āagman read
Computed by āagmanPiotroski F-Score
3
/ 9
3 of 9 F-score tests passed
ROIC
0.3%
vs 11.2% sector median
Margin change
+48
bps OPM YoY
Operating margin vs the same quarter last year
ROE stability
45.9
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +1.69DII +2.76
Latest quarter vs the previous one
Cash-accrual divergence
−1.0%
of assets
Low = accruals track cash flow
Strengths
Watch-outs
−Latest ROCE of 1% trails the sector median of 17%
−Price trades below its 200-day moving average (0.9x)
−Piotroski F-Score of 3/9 is in the weak band (≤3)
Peer comparison
| Name | P/E | Mar Cap ₹ Cr | ROCE % | ROE % |
|---|
Quarterly results
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34 | 56 | 73 | 292 | 334 | 393 | 426 | 327 | 376 | 290 | 428 | 449 |
| Expenses | 72 | 67 | 76 | 228 | 257 | 251 | 243 | 239 | 269 | 273 | 336 | 326 |
| Operating Profit | −39 | −10 | −3 | 64 | 77 | 142 | 183 | 88 | 106 | 17 | 92 | 123 |
| OPM % | −114.7% | −17.9% | −4.1% | 21.9% | 23.1% | 36.1% | 43.0% | 26.9% | 28.2% | 5.9% | 21.5% | 27.4% |
| Other Income | −32 | −74 | 3 | −1 | −1 | −94 | 2 | 2 | 3 | −2 | 2 | 0 |
| Interest | 25 | 26 | 20 | 42 | 45 | 46 | 33 | 27 | 34 | 38 | 23 | 31 |
| Depreciation | 18 | 20 | 20 | 68 | 68 | 69 | 68 | 68 | 70 | 70 | 72 | 72 |
| Profit before tax | −114 | −130 | −40 | −47 | −37 | −67 | 83 | −4 | 6 | −93 | 0 | 20 |
| Net Profit | −114 | −130 | −40 | −6 | −42 | −69 | 98 | 0 | 10 | −89 | 5 | 25 |
| EPS (₹) | — | — | — | — | — | −6.02 | 8.61 | −0.02 | 0.92 | −7.74 | 0.40 | 2.18 |
Profit & Loss
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 21 | 132 | 39 | 172 | 1,445 | 1,422 | 1,543 |
| Expenses | 93 | 229 | 199 | 254 | 978 | 1,117 | 1,204 |
| Operating Profit | −71 | −97 | −161 | −82 | 467 | 304 | 339 |
| OPM % | −338.1% | −73.5% | −412.8% | −47.7% | 32.3% | 21.4% | 22.0% |
| Other Income | 1 | 4 | −526 | −143 | −94 | 5 | 2 |
| Interest | 16 | 68 | 48 | 89 | 166 | 122 | 126 |
| Depreciation | 34 | 70 | 66 | 76 | 274 | 279 | 283 |
| Profit before tax | −121 | −231 | −800 | −391 | −68 | −92 | −67 |
| Net Profit | −121 | −231 | −800 | −391 | −18 | −74 | −49 |
| EPS (₹) | — | — | — | — | −1.57 | −6.44 | −4.24 |
Balance Sheet
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 3 | 4 | 4 | 11 | 11 | — |
| Reserves | 774 | 1,009 | 781 | 392 | 5,869 | 5,820 | — |
| Borrowings | 386 | 1,154 | 864 | 562 | 772 | 1,276 | — |
| Other Liabilities | 96 | 276 | 365 | 468 | 1,005 | 1,197 | — |
| Total Liabilities | 1,258 | 2,442 | 2,015 | 1,426 | 7,657 | 8,304 | — |
| Fixed Assets | 633 | 1,231 | 1,361 | 863 | 6,118 | 6,017 | — |
| CWIP | 431 | 490 | 334 | 188 | 218 | 529 | — |
| Investments | 0 | 0 | 4 | 20 | 16 | 16 | — |
| Other Assets | 195 | 722 | 314 | 356 | 1,305 | 1,742 | — |
| Total Assets | 1,258 | 2,442 | 2,015 | 1,426 | 7,657 | 8,304 | — |
Cash Flows
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | −118 | −416 | −163 | −107 | −68 | 9 |
| Cash from Investing Activity | −207 | −692 | −68 | 511 | −201 | −495 |
| Cash from Financing Activity | 381 | 1,162 | 118 | −391 | 412 | 359 |
| Net Cash Flow | 56 | 54 | −112 | 13 | 143 | −127 |
Ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| ROCE % | — | −10.0 | −12.0 | −12.0 | 6.0 | 1.0 |
| ROE % | — | — | — | — | — | −1.1 |
| EPS (₹) | — | — | — | — | −1.57 | −6.44 |
| Book Value (₹) | — | — | — | — | — | 509.0 |
| Face Value (₹) | — | — | — | — | — | 1 |
| P/E | — | — | — | — | — | — |
| Div Yield % | — | — | — | — | — | 0.00 |
| NPM % | −550.0 | −169.9 | — | −1,348.3 | −1.3 | −5.2 |
| OPM % | −334.0 | −73.0 | −415.0 | −48.0 | 32.0 | 21.0 |
| D/E | 0.50 | 1.14 | 1.10 | 1.42 | 0.13 | 0.22 |
| P/B | — | — | — | — | — | 2.9 |
Growth
Compounded sales growth
5 years+131.0%
3 years+232.0%
TTM+4.0%
Compounded profit growth
5 years+8.0%
3 years+24.0%
TTM−142.0%
Stock price CAGR
Last year−22.0%
Return on equity
5 years−10.0%
3 years−3.0%
Last year−1.0%
Documents
Corporate actions
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman